Insights on Life Sciences
Article
Reimagining life science enterprises with agentic AI
-
Agentic AI is poised to boost the benefits from AI by changing its role from tool to coworker and catalyzing an end-to-end reimagining of the life sciences value chain.
Article
Targeted and timely: Curating aesthetic care for GLP-1 patients
-
Tailored, long-term care models can help aesthetic providers and manufacturers deliver sustained value for GLP-1 patients across...
Report
Shaping the future of Japan’s pharmaceutical operations
-
Japan’s pharma industry, a global innovation leader, faces strain from shifting demand, supply vulnerabilities, and digital disruption....
Podcast
James Zou on integrating AI agents into biology R&D and drug discovery
-
James Zou, an associate professor of machine learning at Stanford University, discusses the role of AI scientists in biotech,...
Article
Fundamentals first: Closing medtech’s value creation gap
-
Top-decile medtech companies drive sustained value creation through strong fundamentals, disciplined capital allocation, and...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.